ReviewJournal of medical case reports2025
Parathyroid adenoma as a cause of hypercalcemia in a patient with breast cancer: a case report and review of the literature.
Review in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with breast cancer can develop hypercalcemia as a metabolic complication of this disease. Bone metastasis is the most common reason responsible for this complication. Yet, hyperparathyroidism is a rare cause of hypercalcemia in these patients. We present a unique case of parathyroid adenoma-related hypercalcemia in a patient with breast cancer and its diagnostic challenges that can alter patient treatment and outcome. CASE PRESENTATION: A 50-year-old Azeris woman presented with lethargy and weakness. She had a history of recently diagnosed breast cancer and had a left mastectomy 2 months ago. She was under chemotherapy at the time the symptoms started. Laboratory tests showed elevated serum calcium levels. Although initially, bone metastasis was considered as a cause of hypercalcemia, later investigation showed no metastasis. Elevated PTH levels along with persistent hypercalcemia after medical treatments revealed the need to do an ultrasonography of the thyroid and parathyroid glands, which showed a mass in the right parathyroid gland. After a surgical consultation, the patient underwent neck exploration. The only enlarged parathyroid gland was in the right lower, and it was removed successfully. Calcium levels decreased significantly after surgery, and the patient's symptoms improved. She was discharged 2 days after surgery and showed no recurrence during follow-ups. The pathology result was compatible with parathyroid adenoma.
conclusionThis case, along with similar ones reported before, shows the challenges of diagnosing the cause of hypercalcemia in patients with breast cancer. Although hyperparathyroidism is rarely encountered, it can be managed and treated with better outcomes than bone metastasis. It highlights the need for more detailed diagnostic protocols to ensure better management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.